Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

NCT06532539 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Neoplasms
Neoplasm Recurrence, Local
Neoplasm Metastasis

Interventions

DRUG: Paclitaxel and Cisplatin
DRUG: Cadonilimab
RADIATION: Radiotherapy

Sponsor

Shandong Cancer Hospital and Institute